Physician profile
James Patrick Dillion
NPI 1619287927
$592.70
in general payments reported to CMS, 2019-2025
14 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $173.13 | 2025 | Farapulse, Watchman Flx |
| Abbvie INC. | $118.27 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $67.18 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $52.12 | 2021 | |
| Sunovion Pharmaceuticals INC. | $49.20 | 2021 | |
| Scilex Pharmaceuticals INC. | $22.39 | 2021 | |
| Ironwood Pharmaceuticals, INC | $16.33 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.00 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.96 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.78 | 2021 | |
| Grifols USA, LLC | $13.71 | 2021 | |
| Nestle Healthcare Nutrition INC. | $12.97 | 2021 | |
| Lilly USA, LLC | $11.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dillion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.